Literature DB >> 7488136

17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro.

C Behl1, M Widmann, T Trapp, F Holsboer.   

Abstract

The potential antioxidant activity of 17-beta estradiol and other steroid hormones in neuronal cells was investigated by studying oxidative stress-induced cell death caused by the neurotoxins amyloid beta protein, hydrogen peroxide and glutamate in the clonal mouse hippocampal cell line HT22. Preincubation of the cells with 10(-5) M 17-beta estradiol prior to addition of the neurotoxins prevented oxidative stress-induced cell damage and ultimately cell death, as detected with cell viability (MTT) and cell lysis (trypan blue exclusion/cell counting; propidium iodide staining) assays. At the DNA level, 17-beta estradiol blocked the DNA degradation caused by glutamate. Other steroid hormones, such as progesterone, aldosterone, corticosterone and the steroid precursor cholesterol, did not protect the cells. The neuronal protection afforded by 17-beta estradiol was estrogen receptor-independent. These data demonstrate a potent neuroprotective activity of the antioxidant 17-beta estradiol, which may have implications for the prevention and treatment of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7488136     DOI: 10.1006/bbrc.1995.2647

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  123 in total

1.  The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties.

Authors:  B Moosmann; C Behl
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  Glutamate receptor requirement for neuronal death from anoxia-reoxygenation: an in Vitro model for assessment of the neuroprotective effects of estrogens.

Authors:  L L Zaulyanov; P S Green; J W Simpkins
Journal:  Cell Mol Neurobiol       Date:  1999-12       Impact factor: 5.046

Review 3.  Alzheimer's disease in man and transgenic mice: females at higher risk.

Authors:  R S Turner
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

4.  The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons.

Authors:  C A Singer; X A Figueroa-Masot; R H Batchelor; D M Dorsa
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

5.  Identification of the novel player deltaEF1 in estrogen transcriptional cascades.

Authors:  E M Chamberlain; M M Sanders
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

Review 6.  Allostasis, allostatic load, and the aging nervous system: role of excitatory amino acids and excitotoxicity.

Authors:  B S McEwen
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

Review 7.  HRT and its effect on normal ageing of the brain and dementia.

Authors:  J Compton; T van Amelsvoort; D Murphy
Journal:  Br J Clin Pharmacol       Date:  2001-12       Impact factor: 4.335

Review 8.  Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.

Authors:  Michel Cyr; Frederic Calon; Marc Morissette; Thérèse Di Paolo
Journal:  J Psychiatry Neurosci       Date:  2002-01       Impact factor: 6.186

9.  Presence of oestrogen receptor type beta in human retina.

Authors:  C Munaut; V Lambert; A Noël; F Frankenne; M Deprez; J M Foidart; J M Rakic
Journal:  Br J Ophthalmol       Date:  2001-07       Impact factor: 4.638

Review 10.  Cellular cofactors for amyloid beta-peptide-induced cell stress. Moving from cell culture to in vivo.

Authors:  S D Yan; A Roher; A M Schmidt; D M Stern
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.